Cargando…
The Role of the Immune Response in Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries; with the aging population, the negative health impacts and costs of the disease will increase dramatically over the next decade. Although the exact cause of AMD is unknown, genetic studies have implicate...
Autores principales: | Whitcup, Scott M., Sodhi, Akrit, Atkinson, John P., Holers, V. Michael, Sinha, Debasish, Rohrer, Bärbel, Dick, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676958/ https://www.ncbi.nlm.nih.gov/pubmed/23762772 http://dx.doi.org/10.1155/2013/348092 |
Ejemplares similares
-
Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration
por: Obert, Elisabeth, et al.
Publicado: (2022) -
Exploring the Therapeutic Potential of Elastase Inhibition in Age-Related Macular Degeneration in Mouse and Human
por: Navneet, Soumya, et al.
Publicado: (2023) -
Increased Nonexudative Age-Related Macular Degeneration Diagnosis Among Medicare Beneficiaries With Rheumatoid Arthritis
por: Schnabolk, Gloriane, et al.
Publicado: (2019) -
Aflibercept more effectively weans patients with neovascular age-related macular degeneration off therapy compared with bevacizumab
por: Cao, Xuan, et al.
Publicado: (2023) -
Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model
por: Parsons, Nathaniel B., et al.
Publicado: (2023)